Donald Ronning, PhD - Professor
Pharmaceutical Sciences
University of Nebraska Medical Center
Full Member
Area(s) of Emphasis:
Pediatric Cancer, Genetics Development Exposures & Injuries, Lifespan Diseases
Research Interests:
Medulloblastoma, Neuroblastoma, Epigenetics, Bromodomains, Histone Deacetylase
Current Research Summary:
Drug discovery for medulloblastoma and neuroblastoma. This includes both characterization of known drug targets as well as validation of target engagement of known cancer drugs and investigational new drugs.